Daewon Pharmaceutical Co., Ltd. (003220.KS) KSC
10,260.00
+80(+0.79%)
Currency In KRW
- General
- Statistics
- Historical Data
- Profile
- Financials
10,260.00
+80(+0.79%)
Currency In KRW
| Market Cap | 256.29B |
| Enterprise Value | 396.18B |
| P/E Ratio | -159.49 |
| PEG Ratio | -1.75 |
| Price/Sales Ratio | 0.36 |
| Price/Book Ratio | 0.83 |
| Enterprise/Revenue | 0.59 |
| Enterprise/EBITDA | 13.21 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | -0 |
| Operating Margin | 0.01 |
| Return On Assets | -0 |
| Return On Equity | -0.01 |
| Revenue | 605.64B |
| Revenue/Share | 28,238.78 |
| Gross Profit | 266.09B |
| EBITDA | 27.23B |
| Net Income | -1.38B |
| Diluted EPS | -64.37 |
| Total Cash | 76.48B |
| Total Cash/Share | 3,565.78 |
| Total Debt | 187.08B |
| Total Debt/Equity | 0.7 |
| Current Ratio | 1.19 |
| Book Value Per Share | 12,982.69 |
| 52-Week Change | -22.51 |
| 52-Week High | 14,700 |
| 52-Week Low | 10,030 |
| Moving Average 50 Days | 11,088.2 |
| Moving Average 200 Days | 12,411.95 |
| Average Volume | 39,268 |
| Shares Outstanding | 21.43M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 211.5 |
| Trailing Annual Dividend Yield | 2.06 |
| Payout Ratio | -4.66 |
| Last Split Factor | 103:100 |
| Last Split Date | March 07, 2022 |